Get startedLog in
    Picture of CARGO Therapeutics logo

    CRGX — CARGO Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapNeutral
    All News

    Cargo Therapeutics Inc Expected To Post A Loss Of 60 Cents A Share: Earnings Preview

    Picture of CARGO Therapeutics logoCARGO Therapeutics
    09/08/2025 01:35
    CARGO Therapeutics Inc CRGX.OQ CRGX.O is expected to  show no change in quarterly revenue when it reports  results  for the period ending September 30 2025

​LSEG's mean analyst estimate for CARGO Therapeutics Inc is for a loss of 60 cents per share.

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 5 "hold" and 1 "sell" or "strong sell."

The mean earnings estimate of analysts had risen by about 7.8% in the last three months. ​

Wall Street's median 12-month price target for CARGO Therapeutics Inc is $5.00, about 10.2% above its last closing price of $4.49

Previous quarterly performance (using preferred earnings measure in US dollars). ​


    QUARTER ENDINGSTARMINESMARTESTIMATE®LSEG IBES ESTIMATEACTUALBEAT, MET, MISSEDSURPRISE %
    Jun. 30 2025-0.45-0.62-1.04Missed-68.4
    Mar. 31 2025-0.57-0.72-0.79Missed-9
    Dec. 31 2024-0.94-0.96-0.95Beat1.2​
    Sep. 30 2024-1.10-1.13-0.88Beat22.2
    ​​Jun. 30 2024-1.01-1.03-1.02Beat0.7
    Mar. 31 2024-1.06-1.05-0.87Beat17.4​
    Dec. 31 2023-1.44-1.44-1.49Missed-3.2
    Sep. 30 2023-2.78-2.78-47.37Missed-1,601.9
    

This summary was machine generated August 9 at 00:35 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

    Recent news on CARGO Therapeutics

    See all news